Results 321 to 330 of about 1,302,625 (339)
Some of the next articles are maybe not open access.

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

European Review for Medical and Pharmacological Sciences, 2021
OBJECTIVE The "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)" disease has caused a worldwide challenging and threatening pandemic (COVID-19), with huge health and economic losses.
S. Meo   +4 more
semanticscholar   +1 more source

SARS-CoV-2 Vaccines.

Journal of the American Medical Association (JAMA), 2021
Shortly after SARS-CoV emerged at the turn of the 21st century, the spike (S) protein (particularly in its prefusion [native] conformation) was identified as the immunodominant antigen of the virus.1 Evaluation of patients with SARS-CoV-2 revealed that ...
C. Creech   +2 more
semanticscholar   +1 more source

Vaccines and Vaccination

New England Journal of Medicine, 2001
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire   +3 more sources

Footrot vaccines and vaccination

Vaccine, 2014
Research on footrot in small ruminants, which is caused by Dichelobacter nodosus, has led to development of vaccines and their application for control, treatment and eradication of the disease in sheep. Footrot vaccines have evolved over decades to contain monovalent whole cell, multivalent recombinant fimbrial, and finally mono or bivalent recombinant
Om P. Dhungyel   +2 more
openaire   +3 more sources

Vaccines

Current Opinion in Immunology, 1990
Much progress has been made towards reaching an understanding of immune responses at the molecular level. This has provided much needed information for identifying the antigens which will afford protection against diseases such as rabies, malaria, whooping cough, hepatitis and acquired immune deficiency syndrome, and for presenting them to the immune ...
openaire   +3 more sources

Vaccines

1995
Publisher Summary This chapter presents the studies of the effects of vaccines. It also reviews the applicability, reliability, sensitivity, and specificity of six standardized case definitions for adverse events following immunization (AEFI) (for fever, generalized convulsive seizures, hypotonic–hyporesponsive episodes, intussusception, nodules, and ...
openaire   +2 more sources

Vaccinations

Clinics in Geriatric Medicine, 1992
Tetanus-diphtheria toxoid, influenza virus vaccines, and pneumococcal vaccine are recommended for older persons in the United States by the Centers for Disease Control. But most high-risk older persons remain unvaccinated, despite experiencing relatively high rates of tetanus, influenza-related complications, and pneumococcal disease, and having ...
openaire   +2 more sources

Vaccines and Vaccinations

Veterinary Clinics of North America: Small Animal Practice, 2001
The rapid proliferation of companion animal vaccines, advances in diagnostic and vaccine technology, and concerns over vaccine safety are clearly among the most important issues practicing veterinarians face as we enter the 21st century. Although many would argue that these are already issues, the future promises to be especially challenging as the ...
openaire   +3 more sources

Cancer vaccines: the next immunotherapy frontier

Nature Cancer, 2022
Matthew J Lin   +6 more
semanticscholar   +1 more source

Therapeutic cancer vaccines

Nature Reviews. Cancer, 2021
Mansi Saxena   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy